Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 25 of 295 for:    IFNA2 AND PEG-interferon alfa-2b

Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01872442
Recruitment Status : Unknown
Verified June 2017 by Poitiers University Hospital.
Recruitment status was:  Active, not recruiting
First Posted : June 7, 2013
Last Update Posted : June 12, 2017
Sponsor:
Information provided by (Responsible Party):
Poitiers University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : December 2018